Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026)

Edgewise Therapeutics' (EWTX) quarterly Amortizatization of Intangibles came in at $53000.0 in Q1 2026, down 97.24% year-on-year from $1.9 million in Q1 2025, and up 6.0% quarter-over-quarter from $50000.0 in Q4 2025.

Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Edgewise Therapeutics has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $53000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $53000.0, down 97.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 111.71% YoY), and the FY2025 annual result was $182000.0, down 98.55% from the prior year.
  • Amortizatization of Intangibles came in at $53000.0 for Q1 2026 at Edgewise Therapeutics, up from $50000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $7.3 million in Q3 2023 to a low of -$4.0 million in Q3 2025.
  • The 5-year median for Amortizatization of Intangibles is $1.4 million (2022), against an average of $1.3 million.
  • Across the five-year window, Amortizatization of Intangibles slumped 358.37% in 2023 and surged 3598.08% in 2025, its largest moves.
  • Edgewise Therapeutics' Amortizatization of Intangibles stood at $1.4 million in 2022, then soared by 57.16% to $2.2 million in 2023, then gained by 19.8% to $2.6 million in 2024, then tumbled by 98.08% to $50000.0 in 2025, then gained by 6.0% to $53000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $53000.0 (Q1 2026), $50000.0 (Q4 2025), and -$4.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Edgewise Therapeutics 3.52 Bn 3.52 Bn - 53,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 53,000.00
Mar 31, 2026 53,000.00
Dec 31, 2025 50,000.00
Dec 31, 2025 50,000.00
Sep 30, 2025 -3.99 Mn
Sep 30, 2025 -3.99 Mn
Jun 30, 2025 2.20 Mn
Jun 30, 2025 2.20 Mn
Mar 31, 2025 1.92 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 2.60 Mn
Dec 31, 2024 2.60 Mn
Sep 30, 2024 3.24 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 6.65 Mn
Jun 30, 2024 6.65 Mn
Mar 31, 2024 52,000.00
Mar 31, 2024 52,000.00
Dec 31, 2023 2.17 Mn
Dec 31, 2023 2.17 Mn